Efficacy of ciprofloxacin in enteric fever: comparison of treatment duration in sensitive and multidrug-resistant Salmonella
- PMID:7573719
- DOI: 10.4269/ajtmh.1995.53.306
Efficacy of ciprofloxacin in enteric fever: comparison of treatment duration in sensitive and multidrug-resistant Salmonella
Abstract
The efficacy of two regimens of ciprofloxacin was compared in a randomized study conducted on 69 patients with enteric fever, 52.2% of whom had infection with multidrug-resistant (MDR) strains of Salmonella typhi or S. paratyphi. Patients were randomly assigned to two regimens (10 days versus 14 days) of ciprofloxacin (500 mg twice a day). The mean +/- SD time required for defervescence was similar for both regimens (4.2 +/- 1.9 days in the 10-day group and 4.9 +/- 2.6 days in the 14-day group). A 100% cure was observed in each treatment group and no serious side effects were observed. Relapse occurred in two patients (14-day regimen). Only one patient (14-day regimen) had growth of S. typhi in stool culture at the time of the first follow-up three days after completion of therapy. Follow-up studies on available patients on two, six, and 12 months after completion of therapy revealed that all patients had negative stool cultures for S. typhi and S. paratyphi. This study indicates that ciprofloxacin may be recommended as an initial therapy for enteric fever for adult men and nonpregnant and nonlactating women in areas where MDR strains of S. typhi and S. paratyphi are prevalent, and that 500 mg twice a day of the drug given for 10 days is as effective as 14 days at the same dosage.
Similar articles
- Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series.Slinger R, Desjardins M, McCarthy AE, Ramotar K, Jessamine P, Guibord C, Toye B.Slinger R, et al.BMC Infect Dis. 2004 Sep 20;4:36. doi: 10.1186/1471-2334-4-36.BMC Infect Dis. 2004.PMID:15380025Free PMC article.
- Treatment with ciprofloxacin in children with typhoid fever.Thomsen LL, Paerregaard A.Thomsen LL, et al.Scand J Infect Dis. 1998;30(4):355-7. doi: 10.1080/00365549850160639.Scand J Infect Dis. 1998.PMID:9817514
- Alternatives to ciprofloxacin use for enteric Fever, United kingdom.Threlfall EJ, de Pinna E, Day M, Lawrence J, Jones J.Threlfall EJ, et al.Emerg Infect Dis. 2008 May;14(5):860-1. doi: 10.3201/eid1405.071184.Emerg Infect Dis. 2008.PMID:18439388Free PMC article.
- [Typhoid and paratyphoid fever].Trawinski H, Wendt S, Lippmann N, Heinitz S, von Braun A, Lübbert C.Trawinski H, et al.Z Gastroenterol. 2020 Feb;58(2):160-170. doi: 10.1055/a-1063-1945. Epub 2020 Feb 12.Z Gastroenterol. 2020.PMID:32050286Review.German.
- Enteric fever: a travel medicine oriented view.Meltzer E, Schwartz E.Meltzer E, et al.Curr Opin Infect Dis. 2010 Oct;23(5):432-7. doi: 10.1097/QCO.0b013e32833c7ca1.Curr Opin Infect Dis. 2010.PMID:20613510Review.
Cited by
- Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability.Davis R, Markham A, Balfour JA.Davis R, et al.Drugs. 1996 Jun;51(6):1019-74. doi: 10.2165/00003495-199651060-00010.Drugs. 1996.PMID:8736621Review.
- Incidence of quinolone resistance over the period 1986 to 1998 in veterinary Salmonella isolates from Germany.Malorny B, Schroeter A, Helmuth R.Malorny B, et al.Antimicrob Agents Chemother. 1999 Sep;43(9):2278-82. doi: 10.1128/AAC.43.9.2278.Antimicrob Agents Chemother. 1999.PMID:10471579Free PMC article.
- Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever).Effa EE, Lassi ZS, Critchley JA, Garner P, Sinclair D, Olliaro PL, Bhutta ZA.Effa EE, et al.Cochrane Database Syst Rev. 2011 Oct 5;2011(10):CD004530. doi: 10.1002/14651858.CD004530.pub4.Cochrane Database Syst Rev. 2011.PMID:21975746Free PMC article.Review.
- Mechanism of therapeutic effectiveness of cefixime against typhoid fever.Matsumoto Y, Ikemoto A, Wakai Y, Ikeda F, Tawara S, Matsumoto K.Matsumoto Y, et al.Antimicrob Agents Chemother. 2001 Sep;45(9):2450-4. doi: 10.1128/AAC.45.9.2450-2454.2001.Antimicrob Agents Chemother. 2001.PMID:11502513Free PMC article.
- Early Economic Evaluation to Identify the Necessary Test Characteristics of a New Typhoid Test to be Cost Effective in Ghana.Frempong SN, Sutton AJ, Davenport C, Barton P.Frempong SN, et al.Pharmacoecon Open. 2020 Mar;4(1):143-157. doi: 10.1007/s41669-019-0159-7.Pharmacoecon Open. 2020.PMID:31377968Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources